Register for the 2018 NIIMBL National Meeting

Latest News

ChromaTan Awarded $2.5 million FDA Contract

September 22, 2017

ChromaTan has been awarded a $2.5 million contract from the FDA to fund the development of a new continuous purification platform for the production of monoclonal antibodies (mAbs) using its Continuous Countercurrent Tangential Chromatography (CCTCâ„¢) technology.

You can read the story from GEN here

Or, visit the ChromaTan website for more information.

Congratulations to the ChromaTan team!

Copyright 2017 NIIMBL. All rights reserved.

Department of Commerce National Institute of Standards and Technology Manufacturing USA USA Bio